What is the Role of HTA for Biosimilars?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

What is the Role of HTA for Biosimilars?

Published:2014 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Mestre-Ferrandiz Jorge,Towse Adrian

Publisher

Elsevier BV

Reference111 articles.

1. ABPI position on biosimilar medicines;The Association of the British Pharmaceutical Industry (ABPI),2013

2. Vale of Glamorgan: All Wales Medicines Strategy Group;All Wales Medicines Strategy Group (AWMSG), 2013a. Form B Guidance Notes,2013

3. Exclusion Criteria;All Wales Medicines Strategy Group (AWMSG),2013

4. Potential Regulatory and Commercial Environment for Biosimilars in Latin America;V F Azevedo;Value in Health Regional Issues,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging the holistic benefits of biosimilars in Europe – part 2: how payers can safeguard the future of a healthy biosimilar market environment;Expert Review of Pharmacoeconomics & Outcomes Research;2024-02-12

2. Economic evaluation of biosimilars for reimbursement purposes – what, when, how?;Journal of Market Access & Health Policy;2020-01-01

3. The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC);Brazilian Journal of Medical and Biological Research;2018

4. Biosimilars: How Can Payers Get Long-Term Savings?;PharmacoEconomics;2016-01-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP